Women's decisional conflict in the pathway of prenatal screening and testing: an explorative study within Finnish public maternity care
- PMID: 32304311
- DOI: 10.1515/jpm-2019-0450
Women's decisional conflict in the pathway of prenatal screening and testing: an explorative study within Finnish public maternity care
Abstract
Objectives To explore women's decisional conflict in the pathway of prenatal screening and testing (PreST) in Finland and to evaluate a counseling service. Methods Self-completion surveys were conducted at two medical settings (screening and further testing) of PreST. Decisional Conflict Scale (DCS) was the main measure. Different types of statistical tests were used to compare women's decisional conflict at different medical settings of PreST, and before-after pre-test counseling. Multivariable linear regressions analyzed the influences of the medical settings and other factors on women's decisional conflict. Results Compared to women in population-based screening, women in further testing (before pre-test counseling) were more likely to feel well informed (P < 0.001), had increased values clarity (P < 0.001), but more likely experienced uncertainty (P = 0.040). Besides medical settings, maternal age, gravidity and previous experience of fetal aneuploidy significantly influenced decisional conflict. After counseling, screen-positive women felt better informed (P < 0.001), had increased values clarity (P < 0.001), perceived more support (P < 0.001), and had better decision certainty (P < 0.001) than before counseling. Conclusions Medical settings influence women's decisional conflict during PreST. Individual counseling is effective in improving screen-positive women's decisional conflict. This research adds knowledge and experience on developing decision-making supports across the pathway of PreST.
Keywords: counseling service; decision-making experience; decisional conflict; medical setting; prenatal screening and testing.
Similar articles
-
Reducing decisional conflict in decisions about prenatal genetic testing: the impact of a dyadic intervention at the start of prenatal care.J Perinat Med. 2024 Apr 29;52(5):467-477. doi: 10.1515/jpm-2023-0442. Print 2024 Jun 25. J Perinat Med. 2024. PMID: 38669584 Free PMC article. Clinical Trial.
-
High risk-What's next? A survey study on decisional conflict, regret, and satisfaction among high-risk pregnant women making choices about further prenatal testing for fetal aneuploidy.Prenat Diagn. 2019 Jul;39(8):635-642. doi: 10.1002/pd.5476. Epub 2019 Jun 19. Prenat Diagn. 2019. PMID: 31083781
-
Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial [ISRCTN22532458].BJOG. 2008 Feb;115(3):339-47. doi: 10.1111/j.1471-0528.2007.01576.x. BJOG. 2008. PMID: 18190370 Clinical Trial.
-
Informed consent: providing information about prenatal examinations.Acta Obstet Gynecol Scand. 2006;85(12):1420-5. doi: 10.1080/00016340600985198. Acta Obstet Gynecol Scand. 2006. PMID: 17260215 Review.
-
Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.Clin Obstet Gynecol. 1993 Sep;36(3):496-509. doi: 10.1097/00003081-199309000-00008. Clin Obstet Gynecol. 1993. PMID: 8403601 Review.
References
-
- Lou S, Mikkelsen L, Hvidman L, Petersen OB, Nielsen CP. Does screening for Down’s syndrome cause anxiety in pregnant women? A systematic review. Acta Obstet Gynecol Scand 2015;94:15–27.
-
- Schoonen H, van Agt H, Essink-Bot M-L, Wildschut H, Steegers E, de Koning H. Informed decision-making in prenatal screening for Down’s syndrome: what knowledge is relevant? Patient Educ Couns 2011;84:265–70.
-
- Sutherland S, Farrell RM, Lockwood C. Genetic screening and testing in an episode-based payment model: preserving patient autonomy. Obstet Gynecol 2014;124:987–91.
-
- Stefanovic V. The importance of pre-and post-test counseling for prenatal cell-free DNA screening for common fetal aneuploidies. Expert Rev Mol Diagn 2019;19:201–15.
-
- Allyse M, Sayres LC, Goodspeed T, Michie M, Cho MK. “Don’t want no risk and don’t want no problems”: public understandings of the risks and benefits of noninvasive prenatal testing in the United States. AJOB Empir Bioeth 2015;6:5–20.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical